Why the study?
Does MEIA compared to RIA yield comparable results for insulin sensitivity and glucose effectiveness in obese subjects?
Does MEIA compared to RIA yield comparable results for insulin sensitivity and glucose effectiveness in obese subjects?
MEIA is a reliable alternative to RIA for measuring insulin sensitivity and glucose effectiveness, with the advantage of lower cross-reactivity with proinsulin.
Answers are grounded in this paper and cite their sources.
MEIA may offer a reliable RIA alternative for insulin sensitivity in obesity; leaves open need for prospective validation.
The purpose of this study was to compare minimal model results of insulin sensitivity and glucose effectiveness using insulin levels measured by a conventional radioimmunoassay (RIA) versus an automated microparticle enzyme immunoassay (MEIA). Thirty obese subjects participated in an insulin-modified frequently sampled intravenous glucose tolerance test. The MEIA exhibited lower day-to-day variability than did the RIA. The MEIA yielded lower insulin values compared to the RIA probably because of the high cross-reactivity with proinsulin in the RIA. The MEIA yielded a good correlation with the RIA for both insulin sensitivity (r = 0.97, p = 0.0001) and for glucose effectiveness (r = 0.98, p = 0.0001). The MEIA did not significantly effect the results of the MinMod analysis and the low cross-reactivity with proinsulin makes MEIA preferable when insulin sensitivity (SI) is measured in patients with diabetes or obese individuals whose insulin:proinsulin ratio is altered.
No takes yet. Share an insight, caveat, or question.
Rood et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: